Correlation Between Aridis Pharmaceuticals and MAIA Biotechnology

Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aridis Pharmaceuticals and MAIA Biotechnology, you can compare the effects of market volatilities on Aridis Pharmaceuticals and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and MAIA Biotechnology.

Diversification Opportunities for Aridis Pharmaceuticals and MAIA Biotechnology

-0.25

Correlation Coefficient

Aridis Pharmaceuticals  MAIA Biotechnology

Very good diversification

The 3 months correlation between Aridis and MAIA is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and MAIA Biotechnology go up and down completely randomly.

Pair Corralation between Aridis Pharmaceuticals and MAIA Biotechnology

If you would invest  226.00  in MAIA Biotechnology on August 16, 2024 and sell it today you would earn a total of  13.00  from holding MAIA Biotechnology or generate 5.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	0.3%
Values	Daily Returns

Aridis Pharmaceuticals  vs.  MAIA Biotechnology

Aridis Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aridis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Aridis Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

MAIA Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MAIA Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Aridis Pharmaceuticals and MAIA Biotechnology

The main advantage of trading using opposite Aridis Pharmaceuticals and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.

The idea behind Aridis Pharmaceuticals and MAIA Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.